![]() |
市場調査レポート
商品コード
1792407
手術用ロボットの市場レポート:製品、用途、エンドユーザー、地域別、2025年~2033年Surgical Robots Market Report by Product, Application, End-User, and Region 2025-2033 |
||||||
カスタマイズ可能
|
手術用ロボットの市場レポート:製品、用途、エンドユーザー、地域別、2025年~2033年 |
出版日: 2025年08月01日
発行: IMARC
ページ情報: 英文 146 Pages
納期: 2~3営業日
|
世界の手術用ロボット市場規模は2024年に62億米ドルに達しました。今後、IMARC Groupは、市場は2033年までに231億米ドルに達し、2025年から2033年にかけて14.96%の成長率(CAGR)を示すと予測しています。骨変性疾患の有病率の増加、改良されたイメージング、ナビゲーションシステム、より器用なロボットアームなどのロボット技術の継続的な進歩、低侵襲処置への嗜好の高まりが、主に市場成長の原動力となっています。
手術件数の増加
慢性的な健康状態や手術を発症しやすい老年人口が世界中で増加していることが、手術用ロボット市場成長の主な原動力となっています。さらに、骨変性疾患の有病率の増加や、関節炎・骨粗鬆症の症例増加による股関節・膝関節置換手術件数の増加が、世界市場を牽引しています。例えば、米国ヘルスケア研究品質庁(Agency for Healthcare Research and Quality)のレポートによると、米国では年間45万件以上の人工股関節置換術が行われています。また、iData Research社の心臓外科市場調査によると、米国では心臓外科手術の件数は毎年90万件を超えており、2029年には130万件に達すると予測されています。これらの疾患の有病率の上昇が、手術を必要とする患者数の増加につながっています。これに加えて、世界中で交通事故が急増していることも、効率的な外科手術とロボットの必要性を高めています。例えば、道路交通高速道路省が発表した報告書によると、2022年中に州および連邦直轄領(UT)から報告された交通事故は合計46万1,312件で、16万8,491人の命が奪われ、44万3,366人が負傷しました。これは前年比で事故が11.9%、死者が9.4%、負傷者が15.3%増加したことを意味します。このような手術件数の大幅な増加は、今後数年間の手術用ロボット市場の需要を促進すると予想されます。
手術手順の複雑化
外科手術の複雑化が進み、より正確で適応性の高い低侵襲手術への要望が拡大していることが、市場全体の見通しをさらに明るいものにしています。さらに、ロボット技術は低侵襲手術で頻繁に使用されています。その名の通り、これらの手術はすべて小さな切開を伴う。この技術は一般的に、痛みの軽減、出血量の減少、入院期間の短縮、早期回復につながり、外科医が手の届きにくい体の部位を手術したり、隠れた部位をよりよく見たりすることを可能にするため、世界中の患者がロボット手術を選択するようになり、市場は拡大しています。これに加えて、顔の身体的特徴を強調する美容整形手術の新たな動向も、精密な外科手術を行うことができる手術用ロボットの需要を増大させています。例えば、RealSelfは2023年リアルセルフ・カルチャー・レポートを発表し、アメリカ人の整形手術に対する意識を調査しました。18歳以上の回答者2,000人以上を対象としたオンライン調査では、アメリカでは4人に1人が少なくとも1回は美容整形治療や施術を受けており、若い世代では社会集団の間で整形手術に肯定的なシフトが見られることが明らかになりました。その結果、複雑な施術の増加がヘルスケア業界における自動化の必要性を高めており、手術用ロボット市場の売上を今後数年間で押し上げると思われます。
進行中の技術的進歩
ロボット工学分野における技術進歩の高まりは、市場全体の見通しを明るいものにしています。外科医に手術部位の詳細なビューを提供する高解像度3Dカメラの統合が進み、手術用ロボットが手術中にリアルタイムで調整を行うのを助けるAIアルゴリズムの組み込みは、ロボット手術開発における重要な進歩の一部です。このような進歩は、ヘルスケアのあり方を一変させました。さらに、さまざまなメーカーが、複雑な手術を最小限の痛みで行える高度なロボットの開発にますます投資しています。例えば、2024年3月、Intuitive Surgical receivedは、10年以上にわたる研究開発を経て、第5世代のマルチポート・ダ・ヴィンチ・ロボットについてFDAの認可を受けました。同社によると、ダヴィンチ5システムは、2016年にFDAの認可を受けた前身であるダヴィンチXiから150以上のアップグレードが加えられています。これには、術中にハンドヘルドツールの感触を模倣するように設計された、フォースフィードバックを提供する外科医用の新しいコントローラーが含まれています。同様に2023年9月、米国医療イノベーションズ(USMI)とジェローム・カナディ先端・生物技術研究所(JCRI-ABTS)は、新しいカナディ・ロボティックAI外科システムの発売を発表しました。冷大気圧プラズマ(CAP)と3次元非接触生体電気パルス電磁場を発生させる世界初の人工知能(AI)ロボットシステムであるとしています。CAPは、手術中に微小な腫瘍細胞を正確に狙い撃ちして除去する一方、がんでない周辺組織の健康は維持します。このような進歩は、市場に明るい見通しをもたらしています。
The global surgical robots market size reached USD 6.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 23.1 Billion by 2033, exhibiting a growth rate (CAGR) of 14.96% during 2025-2033. The growing prevalence of bone degenerative diseases, ongoing advancements in robotic technology, such as improved imaging, navigation systems, and robotic arms with greater dexterity, and rising preference for minimally invasive procedures are primarily driving the market growth.
Rising Number of Surgeries
The increasing geriatric population across the globe, who are more prone to developing chronic health conditions and surgeries is primarily driving the surgical robots market growth. Furthermore, the growing prevalence of bone degenerative diseases and the rising number of hip & knee replacement surgeries due to increasing cases of arthritis & osteoporosis are driving the global market. For instance, according to the Agency for Healthcare Research and Quality report, over 450,000 hip replacement surgeries are performed annually in the US. Additionally, according to a cardiac surgery market study by iData Research, the number of cardiac surgeries exceeds 900,000 procedures each year in the United States with projections for the number to reach 1.3 million by 2029. The rising prevalence of these conditions is leading to an increase in the number of patients requiring surgeries. Besides this, the escalating number of road accidents across the globe is also contributing to the need for efficient surgical procedures and robots. For instance, as per the report published by the Ministry of Road Transport and Highways, a total of 4,61,312 road accidents were reported by States and Union Territories (UTs) during 2022, which claimed 1,68,491 lives and caused injuries to 4,43,366 persons. This marks an increase of 11.9% in accidents, 9.4% in fatalities, and 15.3% in injuries compared to the previous year. Such a massive rise in the number of surgeries is anticipated to propel the surgical robot market demand in the coming years.
Growing Complexity of Surgical Procedures
The increasing complexity of surgical procedures and the expanding desire for minimally invasive operations with more accuracy and adaptability are further creating a positive outlook for the overall market. Moreover, robotic technology is frequently used in minimally invasive surgeries. As the name implies, these operations all involve small incisions. This technique typically leads to less pain, less blood loss, shorter hospital stays, and quicker recoveries, allowing surgeons to operate on hard-to-reach body parts and get a better view of hidden areas, encouraging patients worldwide to choose robotic surgery and growing market. Besides this, the emerging trend of cosmetic surgery to enhance the physical features of the face is also augmenting the demand for surgery robots that can carry out precise surgical procedures. For instance, RealSelf released its 2023 RealSelf Culture Report, exploring Americans' attitudes toward plastic surgery. The online survey of more than 2,000 respondents of 18 years old and older, revealed that one in four people in America had at least one cosmetic treatment or procedure and that younger generations have experienced a positive plastic surgery shift among social groups. Consequently, the rising number of complex procedures is bolstering the need for automation in the healthcare industry, which in turn will propel the surgical robots market revenue in the coming years.
Ongoing Technological Advancements
The rising technological advancements in the field of robotics are fostering a positive outlook for the overall market. The growing integration of High-definition 3D cameras to provide surgeons with a detailed view of the surgical site and the incorporation of AI algorithms to help surgical robots make real-time adjustments during surgery are some of the significant advancements in robotic surgery development. Such advancements have transformed the way healthcare operates. Moreover, various manufacturers are increasingly investing in the development of advanced robots that can perform complex surgeries with minimal pain. For instance, in March 2024, Intuitive Surgical received an FDA green light for the fifth generation of its multiport da Vinci robot, following more than a decade of research and development. The company said the da Vinci 5 system added more than 150 upgrades over its predecessor, the da Vinci Xi, which received its agency green light in 2016. It includes new controllers for surgeons that offer force feedback, designed to mimic the feel of handheld tools during a procedure. Similarly, in September 2023, US Medical Innovations (USMI) and the Jerome Canady Research Institute for Advanced and Biological Technological Sciences (JCRI-ABTS) announced the launch of the new Canady Robotic AI Surgical System. It is claimed to be the world's first artificial intelligence (AI) robotic system that generates cold atmospheric plasma (CAP) and a three-dimensional non-contact bioelectric pulse electromagnetic field. CAP precisely targets and eliminates microscopic tumor cells during surgery while preserving the health of non-cancerous surrounding tissue. Such advancements are fostering a positive outlook for the market.
Instruments and accessories hold the majority of the total market share
Surgical robots use a variety of specialized instruments to perform procedures with precision and accuracy. These instruments are typically mounted on robotic arms and controlled by the surgeon using a console. Graspers, scissors, needle drivers, retractors, and suction tools are some of the common instruments found in surgical robots. Moreover, these instruments work together to enable surgeons to perform a wide range of procedures with greater precision, control, and less invasive techniques than traditional surgery.
Orthopedic surgery currently exhibits a clear dominance in the market
The increasing geriatric population across the globe, which is more prone to developing joint and muscle-related issues, is primarily driving the growth of this segment. According to the Australian Institute of Health and Welfare (AIHW) statistics, the total knee replacement rate for osteoarthritis increased by about 38% from 2005-2006 to 2017-2018. Moreover, as per the International Congress for Joint Reconstruction in March 2018, total number of primary hip replacement and knee replacement procedures is projected to reach 635,000 (171.0% increase) & 1.28 million (189.0% increase), respectively, by 2030 and 1.23 million (330.0% growth) & 2.60 million (382.0% growth) by 2060. Such a massive rise in the number of orthopedic surgeries is leading to the dominance of this segment.
Hospitals account for the largest market share
Inpatient facilities, such as hospitals, usually have the financial resources and high patient volume to justify the investment in costly surgical robotic systems. In addition, they possess the infrastructure and skilled personnel necessary to operate and maintain these advanced technologies.
North America holds the largest market share
North America holds the largest share of the global surgical robot market. The market in the region is growing due to the rising number of surgical procedures associated with colorectal and urological conditions and increasing healthcare expenditures. Moreover, in North America, the demand for General & Plastic Surgery Devices is driven by the high prevalence of cosmetic procedures and advanced healthcare infrastructure. Besides this, each year in the United States, surgeons perform approximately 64 million surgical procedures, ranging from tooth extraction to open heart surgery. Furthermore, various regional manufacturers are increasingly investing in the development of advanced surgical robots, which is creating a positive outlook for the market. For instance, in September 2024, Medtronic announced the launch of a new robot-assisted surgery platform that is more flexible and cost-effective than systems presently on the market.